Literature DB >> 2760031

Characterization of a novel membrane glycoprotein involved in platelet activation.

J L Scott1, S M Dunn, B Jin, A J Hillam, S Walton, M C Berndt, A W Murray, G W Krissansen, G F Burns.   

Abstract

When platelets bind certain specific ligands they are induced to secrete the contents of their cytoplasmic granules and to aggregate. Studies of the molecular events accompanying this vital physiological response have led to a greater understanding of cell activation in general since the pathways involved are common to a number of cell types. By contrast most of the information about the cell surface molecules that initiate signal transduction has emerged from work on T lymphocyte activation, a process essential to the initiation of the immune response. We have described an activation antigen on T lymphocytes that is involved in the differentiation of these cells. In the present report it is demonstrated that the antigen is expressed on the platelet membrane with about 1,200 copies/platelet. A monoclonal antibody detecting this antigen stimulates platelet secretion and aggregation with a half-maximal response at approximately 10(-8) M. Characterization of the antigen, termed PTA1, reveals a glycoprotein of Mr 67,000 showing extensive N-linked carbohydrate, much of which appears to be heavily sialated. The amino-terminal sequence of PTA1, EEVLWHTSVPFAEXMSLEXVYPSM, indicates that the protein has not previously been characterized. Preliminary investigation of the mechanism by which PTA1 mediates platelet activation suggests involvement of protein kinase C and the 47-kDa protein of platelets is rapidly phosphorylated upon antibody-mediated activation. During this process PTA1 is also phosphorylated, as it is following platelet activation by the other agonists, collagen, thrombin, and 12-O-tetradecanoylphorbol 13-acetate. These results provide the first example of a cell surface glycoprotein that is directly involved in both platelet and T lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760031

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions.

Authors:  Zhuwei Xu; Boquan Jin
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

3.  Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36.

Authors:  D J Dorahy; L F Lincz; C J Meldrum; G F Burns
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

Review 4.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

5.  Identification of CD226 ligand on colo205 cell surface.

Authors:  Kai Sun; Bo-Quan Jin; Qi Feng; Yong Zhu; Kun Yang; Xue-Song Liu; Bang-Quan Dong
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.

Authors:  U P Naik; Y H Ehrlich; E Kornecki
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Capture by chemical crosslinkers provides evidence that integrin alpha IIb beta 3 forms a complex with protein tyrosine kinases in intact platelets.

Authors:  D J Dorahy; M C Berndt; G F Burns
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

8.  Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112.

Authors:  Virginie Prod'homme; Daniel M Sugrue; Richard J Stanton; Akio Nomoto; James Davies; Carole R Rickards; Daniel Cochrane; Melanie Moore; Gavin W G Wilkinson; Peter Tomasec
Journal:  J Gen Virol       Date:  2010-04-21       Impact factor: 3.891

9.  Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients.

Authors:  Zhuwei Xu; Tao Zhang; Ran Zhuang; Yun Zhang; Wei Jia; Chaojun Song; Kun Yang; Angang Yang; Boquan Jin
Journal:  BMC Immunol       Date:  2009-06-02       Impact factor: 3.615

10.  Extensive serum biomarker analysis in the prethrombotic state of recurrent spontaneous abortion.

Authors:  Ying Wu; Mingwei Xin; Qian Han; Jingshang Wang; Xiaodan Yin; Junqin He; Chenghong Yin
Journal:  J Cell Mol Med       Date:  2021-06-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.